{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:18:12Z","timestamp":1793017092693,"version":"4.5.0"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s43440-025-00717-6","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T20:17:32Z","timestamp":1742674652000},"page":"576-592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Unveiling the role of Na\u207a\/K\u207a-ATPase pump: neurodegenerative mechanisms and therapeutic horizons"],"prefix":"10.1007","volume":"77","author":[{"given":"Ramandeep Kaur","family":"Sidhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousik","family":"Maparu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamsher","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2450-2975","authenticated-orcid":false,"given":"Khadga Raj","family":"Aran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"issue":"3","key":"717_CR1","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3390\/ijms23031851","volume":"23","author":"RNL Lamptey","year":"2022","unstructured":"Lamptey RNL, Chaulagain B, Trivedi R, Gothwal A, Layek B, Singh J. A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics. Int J Mol Sci. 2022;23(3):1851. https:\/\/doi.org\/10.3390\/ijms23031851.","journal-title":"Int J Mol Sci"},{"key":"717_CR2","doi-asserted-by":"publisher","first-page":"104853","DOI":"10.1016\/j.neuint.2020.104853","volume":"141","author":"H J\u0119\u015bko","year":"2020","unstructured":"J\u0119\u015bko H, Cie\u015blik M, Gromadzka G, Adamczyk A. Dysfunctional proteins in neuropsychiatric disorders: from neurodegeneration to autism spectrum disorders. Neurochem Int. 2020;141:104853. https:\/\/doi.org\/10.1016\/j.neuint.2020.104853.","journal-title":"Neurochem Int"},{"issue":"1","key":"717_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41435-022-00192-6","volume":"24","author":"SJ Virolainen","year":"2023","unstructured":"Virolainen SJ, VonHandorf A, Viel KCMF, Weirauch MT, Kottyan LC. Gene-environment interactions and their impact on human health. Genes Immun. 2023;24(1):1\u201311. https:\/\/doi.org\/10.1038\/s41435-022-00192-6.","journal-title":"Genes Immun"},{"issue":"3","key":"717_CR4","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/glia.23699","volume":"68","author":"S Song","year":"2020","unstructured":"Song S, Luo L, Sun B, Sun D. Roles of glial ion transporters in brain diseases. Glia. 2020;68(3):472\u201394. https:\/\/doi.org\/10.1002\/glia.23699.","journal-title":"Glia"},{"issue":"1","key":"717_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4021\/jocmr2010.02.263w","volume":"2","author":"M Suhail","year":"2010","unstructured":"Suhail M, Na K-ATP. Ubiquitous multifunctional transmembrane protein and its relevance to various pathophysiological conditions. J Clin Med Res. 2010;2(1):1\u201317. https:\/\/doi.org\/10.4021\/jocmr2010.02.263w.","journal-title":"J Clin Med Res"},{"issue":"24","key":"717_CR6","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.3390\/cells11244075","volume":"11","author":"X Zhang","year":"2022","unstructured":"Zhang X, Lee W, Bian JS. Recent advances in the study of Na+\/K+-ATPase in neurodegenerative diseases. Cells. 2022;11(24):4075. https:\/\/doi.org\/10.3390\/cells11244075.","journal-title":"Cells"},{"issue":"1","key":"717_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10158-018-0221-7","volume":"19","author":"AS Pivovarov","year":"2018","unstructured":"Pivovarov AS, Calahorro F, Walker RJ. Na+\/K+-pump and neurotransmitter membrane receptors. Invert Neurosci. 2018;19(1):1. https:\/\/doi.org\/10.1007\/s10158-018-0221-7.","journal-title":"Invert Neurosci"},{"issue":"18","key":"717_CR8","doi-asserted-by":"publisher","first-page":"8542","DOI":"10.1073\/pnas.91.18.8542","volume":"91","author":"G Blanco","year":"1994","unstructured":"Blanco G, Koster JC, Mercer RW. The alpha subunit of the Na,K-ATPase specifically and stably associates into oligomers. Proc Natl Acad Sci U S A. 1994;91(18):8542\u20136. https:\/\/doi.org\/10.1073\/pnas.91.18.8542.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"717_CR9","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1002\/cne.24924","volume":"528","author":"K Murata","year":"2020","unstructured":"Murata K, Kinoshita T, Ishikawa T, Kuroda K, Hoshi M, Fukazawa Y. Region- and neuronal-subtype-specific expression of Na,K-ATPase alpha and beta subunit isoforms in the mouse brain. J Comp Neurol. 2020;528(16):2654\u201378. https:\/\/doi.org\/10.1002\/cne.24924.","journal-title":"J Comp Neurol"},{"issue":"2","key":"717_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.59566\/IJBS.2014.10085","volume":"10","author":"GR de Lores Arnaiz","year":"2014","unstructured":"de Lores Arnaiz GR, Ordieres MG. Brain Na(+), K(+)-ATPase activity in aging and disease. Int J Biomed Sci. 2014;10(2):85\u2013102.","journal-title":"Int J Biomed Sci"},{"key":"717_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.brainres.2009.09.013","volume":"1302","author":"J Ben","year":"2009","unstructured":"Ben J, Soares FM, Cechetti F, Vuaden FC, Bonan CD, Netto CA, et al. Exercise effects on activities of Na(+),K(+)-ATPase, acetylcholinesterase and adenine nucleotides hydrolysis in ovariectomized rats. Brain Res. 2009;1302:248\u201355. https:\/\/doi.org\/10.1016\/j.brainres.2009.09.013.","journal-title":"Brain Res"},{"key":"717_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1152\/physiol.00008.2008","volume":"23","author":"J Tian","year":"2008","unstructured":"Tian J, Xie ZJ. The Na-K-ATPase and calcium-signaling microdomains. Physiol (Bethesda). 2008;23:205\u201311. https:\/\/doi.org\/10.1152\/physiol.00008.2008.","journal-title":"Physiol (Bethesda)"},{"issue":"1","key":"717_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.apsb.2024.10.004","volume":"15","author":"UC Dash","year":"2025","unstructured":"Dash UC, Bhol NK, Swain SK, Samal RR, Nayak PK, Raina V, et al. Oxidative stress and inflammation in the pathogenesis of neurological disorders: mechanisms and implications. Acta Pharm Sin B. 2025;15(1):15\u201334. https:\/\/doi.org\/10.1016\/j.apsb.2024.10.004.","journal-title":"Acta Pharm Sin B"},{"issue":"28","key":"717_CR14","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.1523\/JNEUROSCI.0265-19.2019","volume":"39","author":"S Mohan","year":"2019","unstructured":"Mohan S, Tiwari MN, Biala Y, Yaari Y. Regulation of neuronal Na+\/K+-ATPase by specific protein kinases and protein phosphatases. J Neurosci. 2019;39(28):5440\u201351. https:\/\/doi.org\/10.1523\/JNEUROSCI.0265-19.2019.","journal-title":"J Neurosci"},{"issue":"5","key":"717_CR15","doi-asserted-by":"publisher","first-page":"eabc5062","DOI":"10.1126\/sciadv.abc5062","volume":"7","author":"L Cao","year":"2021","unstructured":"Cao L, Xiong S, Wu Z, Ding L, Zhou Y, Sun H, et al. Anti-Na+\/K+-ATPase immunotherapy ameliorates \u03b1-synuclein pathology through activation of Na+\/K+-ATPase \u03b11-dependent autophagy. Sci Adv. 2021;7(5):eabc5062. https:\/\/doi.org\/10.1126\/sciadv.abc5062.","journal-title":"Sci Adv"},{"issue":"11","key":"717_CR16","doi-asserted-by":"publisher","first-page":"6122","DOI":"10.3390\/ijms25116122","volume":"25","author":"RG Contreras","year":"2024","unstructured":"Contreras RG, Torres-Carrillo A, Flores-Maldonado C, Shoshani L, Ponce A. Na+\/K+-ATPase: more than an electrogenic pump. Int J Mol Sci. 2024;25(11):6122. https:\/\/doi.org\/10.3390\/ijms25116122.","journal-title":"Int J Mol Sci"},{"key":"717_CR17","unstructured":"Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular Biology of the Cell. Ion Channels and the Electrical Properties of Membranes. 4th edition. New York: Garland Science; 2002. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK26910\/"},{"issue":"Suppl 2","key":"717_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12028-021-01326-w","volume":"35","author":"JA Hellas","year":"2021","unstructured":"Hellas JA, Andrew RD. Neuronal swelling: A Non-osmotic consequence of spreading depolarization. Neurocrit Care. 2021;35(Suppl 2):112\u201334. https:\/\/doi.org\/10.1007\/s12028-021-01326-w.","journal-title":"Neurocrit Care"},{"key":"717_CR19","doi-asserted-by":"publisher","first-page":"670346","DOI":"10.3389\/fncel.2021.670346","volume":"15","author":"RM Ryan","year":"2021","unstructured":"Ryan RM, Ingram SL, Scimemi A. Regulation of glutamate, GABA and dopamine transporter uptake, surface mobility and expression. Front Cell Neurosci. 2021;15:670346. https:\/\/doi.org\/10.3389\/fncel.2021.670346.","journal-title":"Front Cell Neurosci"},{"issue":"16","key":"717_CR20","doi-asserted-by":"publisher","first-page":"9381","DOI":"10.3390\/ijms23169381","volume":"23","author":"F Wang","year":"2022","unstructured":"Wang F, Xie X, Xing X, Sun X. Excitatory synaptic transmission in ischemic stroke: A new outlet for classical neuroprotective strategies. Int J Mol Sci. 2022;23(16):9381. https:\/\/doi.org\/10.3390\/ijms23169381.","journal-title":"Int J Mol Sci"},{"key":"717_CR21","unstructured":"Pirahanchi Y, Jessu R, Aeddula NR, Physiology. Sodium Potassium Pump. [Updated 2023 Mar 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537088\/"},{"issue":"8","key":"717_CR22","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1016\/S0021-9258(19)69518-9","volume":"256","author":"GL Peterson","year":"1981","unstructured":"Peterson GL, Hokin LE. Molecular weight and stoichiometry of the sodium- and potassium-activated adenosine triphosphatase subunits. J Biol Chem. 1981;256(8):3751\u201361.","journal-title":"J Biol Chem"},{"issue":"5","key":"717_CR23","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/MNH.0b013e3283036cbf","volume":"17","author":"K Geering","year":"2008","unstructured":"Geering K. Functional roles of Na,K-ATPase subunits. Curr Opin Nephrol Hypertens. 2008;17(5):526\u201332. https:\/\/doi.org\/10.1097\/MNH.0b013e3283036cbf.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"7245","key":"717_CR24","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature07939","volume":"459","author":"T Shinoda","year":"2009","unstructured":"Shinoda T, Ogawa H, Cornelius F, Toyoshima C. Crystal structure of the sodium-potassium pump at 2.4 A resolution. Nature. 2009;459(7245):446\u201350. https:\/\/doi.org\/10.1038\/nature07939.","journal-title":"Nature"},{"key":"717_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fphys.2016.00161","volume":"7","author":"TJ Isaksen","year":"2016","unstructured":"Isaksen TJ, Lykke-Hartmann K. Insights into the pathology of the \u03b12-Na(+)\/K(+)-ATPase in neurological disorders; lessons from animal models. Front Physiol. 2016;7:161. https:\/\/doi.org\/10.3389\/fphys.2016.00161.","journal-title":"Front Physiol"},{"key":"717_CR26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1146\/annurev.biochem.71.102201.141218","volume":"71","author":"JH Kaplan","year":"2002","unstructured":"Kaplan JH. Biochemistry of Na, K-ATPase. Annu Rev Biochem. 2002;71:511\u201335. https:\/\/doi.org\/10.1146\/annurev.biochem.71.102201.141218.","journal-title":"Annu Rev Biochem"},{"issue":"11","key":"717_CR27","doi-asserted-by":"publisher","first-page":"e79127","DOI":"10.1371\/journal.pone.0079127","volume":"8","author":"C Henriksen","year":"2013","unstructured":"Henriksen C, Kjaer-Sorensen K, Einholm AP, Madsen LB, Momeni J, Bendixen C, et al. Molecular cloning and characterization of Porcine Na\u207a\/K\u207a-ATPase isoforms \u03911, \u03912, \u03913 and the ATP1A3 promoter. PLoS ONE. 2013;8(11):e79127. https:\/\/doi.org\/10.1371\/journal.pone.0079127.","journal-title":"PLoS ONE"},{"key":"717_CR28","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.2741\/1724","volume":"10","author":"CJ Rivard","year":"2005","unstructured":"Rivard CJ, Almeida NE, Berl T, Capasso JM. The gamma subunit of Na\/K-ATPase: an exceptional, small transmembrane protein. Front Biosci. 2005;10:2604\u201310. https:\/\/doi.org\/10.2741\/1724.","journal-title":"Front Biosci"},{"issue":"2","key":"717_CR29","doi-asserted-by":"publisher","first-page":"F241","DOI":"10.1152\/ajprenal.00126.2005","volume":"290","author":"K Geering","year":"2006","unstructured":"Geering K. FXYD proteins: new regulators of Na-K-ATPase. Am J Physiol Ren Physiol. 2006;290(2):F241\u201350. https:\/\/doi.org\/10.1152\/ajprenal.00126.2005.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"9","key":"717_CR30","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1111\/cns.13893","volume":"28","author":"J Sun","year":"2022","unstructured":"Sun J, Zheng Y, Chen Z, Wang Y. The role of Na+ -K+ -ATPase in the epileptic brain. CNS Neurosci Ther. 2022;28(9):1294\u2013302. https:\/\/doi.org\/10.1111\/cns.13893.","journal-title":"CNS Neurosci Ther"},{"key":"717_CR31","doi-asserted-by":"publisher","first-page":"1150171","DOI":"10.3389\/fendo.2023.1150171","volume":"14","author":"M Obradovic","year":"2023","unstructured":"Obradovic M, Sudar-Milovanovic E, Gluvic Z, Banjac K, Rizzo M, Isenovic ER. The Na+\/K+-ATPase: A potential therapeutic target in cardiometabolic diseases. Front Endocrinol (Lausanne). 2023;14:1150171. https:\/\/doi.org\/10.3389\/fendo.2023.1150171.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"36","key":"717_CR32","doi-asserted-by":"publisher","first-page":"27838","DOI":"10.1074\/jbc.M002950200","volume":"275","author":"J Liu","year":"2000","unstructured":"Liu J, Tian J, Haas M, Shapiro JI, Askari A, Xie Z. Ouabain interaction with cardiac Na+\/K+-ATPase initiates signal cascades independent of changes in intracellular Na\u2009+\u2009and Ca2\u2009+\u2009concentrations. J Biol Chem. 2000;275(36):27838\u201344. https:\/\/doi.org\/10.1074\/jbc.M002950200.","journal-title":"J Biol Chem"},{"issue":"12","key":"717_CR33","doi-asserted-by":"publisher","first-page":"7192","DOI":"10.1128\/MCB.18.12.7192","volume":"18","author":"F Walker","year":"1998","unstructured":"Walker F, Kato A, Gonez LJ, Hibbs ML, Pouliot N, Levitzki A, et al. Activation of the Ras\/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation. Mol Cell Biol. 1998;18(12):7192\u2013204. https:\/\/doi.org\/10.1128\/MCB.18.12.7192.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"717_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1124\/mi.3.3.157","volume":"3","author":"Z Xie","year":"2003","unstructured":"Xie Z, Cai T. Na+-K+--ATPase-mediated signal transduction: from protein interaction to cellular function. Mol Interv. 2003;3(3):157\u201368. https:\/\/doi.org\/10.1124\/mi.3.3.157.","journal-title":"Mol Interv"},{"issue":"6","key":"717_CR35","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3390\/molecules22060990","volume":"22","author":"X Cui","year":"2017","unstructured":"Cui X, Xie Z. Protein interaction and Na\/K-ATPase-Mediated signal transduction. Molecules. 2017;22(6):990. https:\/\/doi.org\/10.3390\/molecules22060990.","journal-title":"Molecules"},{"issue":"5","key":"717_CR36","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.3892\/ol.2016.5110","volume":"12","author":"L Li","year":"2016","unstructured":"Li L, Zhao GD, Shi Z, Qi LL, Zhou LY, Fu ZX. The Ras\/Raf\/MEK\/ERK signaling pathway and its role in the occurrence and development of HCC. Oncol Lett. 2016;12(5):3045\u201350. https:\/\/doi.org\/10.3892\/ol.2016.5110.","journal-title":"Oncol Lett"},{"issue":"2","key":"717_CR37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00018-012-1039-9","volume":"70","author":"L Reinhard","year":"2013","unstructured":"Reinhard L, Tidow H, Clausen MJ, Nissen P. Na(+),K (+)-ATPase as a Docking station: protein-protein complexes of the Na(+),K (+)-ATPase. Cell Mol Life Sci. 2013;70(2):205\u201322. https:\/\/doi.org\/10.1007\/s00018-012-1039-9.","journal-title":"Cell Mol Life Sci"},{"key":"717_CR38","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-physiol-021909-135725","volume":"72","author":"JB Lingrel","year":"2010","unstructured":"Lingrel JB. The physiological significance of the cardiotonic steroid\/ouabain-binding site of the Na,K-ATPase. Annu Rev Physiol. 2010;72:395\u2013412. https:\/\/doi.org\/10.1146\/annurev-physiol-021909-135725.","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"717_CR39","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3390\/cells11040706","volume":"11","author":"AY Baev","year":"2022","unstructured":"Baev AY, Vinokurov AY, Novikova IN, Dremin VV, Potapova EV, Abramov AY. Interaction of mitochondrial calcium and ROS in neurodegeneration. Cells. 2022;11(4):706. https:\/\/doi.org\/10.3390\/cells11040706.","journal-title":"Cells"},{"issue":"3","key":"717_CR40","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00424-008-0470-0","volume":"457","author":"Z Li","year":"2009","unstructured":"Li Z, Xie Z. The Na\/K-ATPase\/Src complex and cardiotonic steroid-activated protein kinase cascades. Pflugers Arch. 2009;457(3):635\u201344. https:\/\/doi.org\/10.1007\/s00424-008-0470-0.","journal-title":"Pflugers Arch"},{"issue":"1","key":"717_CR41","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1523-1755.2004.00723.x","volume":"66","author":"J Liu","year":"2004","unstructured":"Liu J, Kesiry R, Periyasamy SM, Malhotra D, Xie Z, Shapiro JI. Ouabain induces endocytosis of plasmalemmal Na\/K-ATPase in LLC-PK1 cells by a clathrin-dependent mechanism. Kidney Int. 2004;66(1):227\u201341. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00723.x.","journal-title":"Kidney Int"},{"issue":"1","key":"717_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1124\/pr.108.000711","volume":"61","author":"AY Bagrov","year":"2009","unstructured":"Bagrov AY, Shapiro JI, Fedorova OV. Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacol Rev. 2009;61(1):9\u201338. https:\/\/doi.org\/10.1124\/pr.108.000711.","journal-title":"Pharmacol Rev"},{"issue":"6","key":"717_CR43","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1083\/jcb.200712022","volume":"182","author":"T Cai","year":"2008","unstructured":"Cai T, Wang H, Chen Y, Liu L, Gunning WT, Quintas LE, Xie ZJ. Regulation of caveolin-1 membrane trafficking by the Na\/K-ATPase. J Cell Biol. 2008;182(6):1153\u201369. https:\/\/doi.org\/10.1083\/jcb.200712022.","journal-title":"J Cell Biol"},{"key":"717_CR44","doi-asserted-by":"publisher","first-page":"588664","DOI":"10.3389\/fphys.2020.588664","volume":"11","author":"KB Gagnon","year":"2021","unstructured":"Gagnon KB, Delpire E. Sodium transporters in human health and disease. Front Physiol. 2021;11:588664. https:\/\/doi.org\/10.3389\/fphys.2020.588664.","journal-title":"Front Physiol"},{"issue":"1","key":"717_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40035-021-00278-7","volume":"11","author":"M Verma","year":"2022","unstructured":"Verma M, Lizama BN, Chu CT. Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration. Transl Neurodegener. 2022;11(1):3. https:\/\/doi.org\/10.1186\/s40035-021-00278-7.","journal-title":"Transl Neurodegener"},{"issue":"4","key":"717_CR46","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3233\/JAD-161118","volume":"57","author":"R Kandimalla","year":"2017","unstructured":"Kandimalla R, Reddy PH. Therapeutics of neurotransmitters in Alzheimer\u2019s disease. J Alzheimers Dis. 2017;57(4):1049\u201369. https:\/\/doi.org\/10.3233\/JAD-161118.","journal-title":"J Alzheimers Dis"},{"key":"717_CR47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13041-024-01118-1","volume":"17","author":"A Azargoonjahromi","year":"2024","unstructured":"Azargoonjahromi A. The duality of amyloid-\u03b2: its role in normal and Alzheimer\u2019s disease States. Mol Brain. 2024;17:44. https:\/\/doi.org\/10.1186\/s13041-024-01118-1.","journal-title":"Mol Brain"},{"issue":"4","key":"717_CR48","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3233\/JAD-161088","volume":"57","author":"E T\u00f6nnies","year":"2017","unstructured":"T\u00f6nnies E, Trushina E, Oxidative, Stress. Synaptic dysfunction, and Alzheimer\u2019s disease. J Alzheimers Dis. 2017;57(4):1105\u201321. https:\/\/doi.org\/10.3233\/JAD-161088.","journal-title":"J Alzheimers Dis"},{"issue":"17","key":"717_CR49","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.3390\/cells11172753","volume":"11","author":"IY Petrushanko","year":"2022","unstructured":"Petrushanko IY, Tverskoi AM, Barykin EP, Petrovskaya AV, Strelkova MA, Leonova OG, et al. Na,K-ATPase acts as a Beta-Amyloid receptor triggering Src kinase activation. Cells. 2022;11(17):2753. https:\/\/doi.org\/10.3390\/cells11172753.","journal-title":"Cells"},{"issue":"6","key":"717_CR50","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/molecules27061816","volume":"27","author":"ZR Chen","year":"2022","unstructured":"Chen ZR, Huang JB, Yang SL, Hong FF. Role of cholinergic signaling in Alzheimer\u2019s disease. Molecules. 2022;27(6):1816. https:\/\/doi.org\/10.3390\/molecules27061816.","journal-title":"Molecules"},{"key":"717_CR51","doi-asserted-by":"publisher","first-page":"27738","DOI":"10.1038\/srep27738","volume":"6","author":"IY Petrushanko","year":"2016","unstructured":"Petrushanko IY, Mitkevich VA, Anashkina AA, Adzhubei AA, Burnysheva KM, Lakunina VA, et al. Direct interaction of beta-amyloid with Na,K-ATPase as a putative regulator of the enzyme function. Sci Rep. 2016;6:27738. https:\/\/doi.org\/10.1038\/srep27738.","journal-title":"Sci Rep"},{"key":"717_CR52","doi-asserted-by":"publisher","unstructured":"de Paula VJR, Guimar\u00e3es FM, Diniz BS, Forlenza OV. Neurobiological pathways to Alzheimer\u2019s disease: Amyloid-beta, TAU protein or both? Dement Neuropsychol. 2009 Jul-Sep;3(3):188\u201394. https:\/\/doi.org\/10.1590\/S1980-57642009DN30300003","DOI":"10.1590\/S1980-57642009DN30300003"},{"issue":"4","key":"717_CR53","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-160612","volume":"57","author":"R Rajmohan","year":"2017","unstructured":"Rajmohan R, Reddy PH. Amyloid-Beta and phosphorylated Tau accumulations cause abnormalities at synapses of Alzheimer\u2019s disease neurons. J Alzheimers Dis. 2017;57(4):975\u201399. https:\/\/doi.org\/10.3233\/JAD-160612.","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"717_CR54","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, et al. The Amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry. 2021;26(10):5481\u2013503. https:\/\/doi.org\/10.1038\/s41380-021-01249-0.","journal-title":"Mol Psychiatry"},{"key":"717_CR55","doi-asserted-by":"publisher","first-page":"916312","DOI":"10.3389\/fphar.2022.916312","volume":"13","author":"JA Leite","year":"2022","unstructured":"Leite JA, P\u00f4\u00e7as E, Maia GS, Barbosa L, Quintas LEM, Kawamoto EM, da Silva MLC, Scavone C, de Carvalho LED. Effect of Ouabain on calcium signaling in rodent brain: A systematic review of in vitro studies. Front Pharmacol. 2022;13:916312. https:\/\/doi.org\/10.3389\/fphar.2022.916312.","journal-title":"Front Pharmacol"},{"issue":"3","key":"717_CR56","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1523\/JNEUROSCI.17-03-01046.1997","volume":"17","author":"RJ Mark","year":"1997","unstructured":"Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP. Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J Neurosci. 1997;17(3):1046\u201354. https:\/\/doi.org\/10.1523\/JNEUROSCI.17-03-01046.1997.","journal-title":"J Neurosci"},{"issue":"5","key":"717_CR57","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/s0361-9230(97)00382-1","volume":"46","author":"GM Bores","year":"1998","unstructured":"Bores GM, Smith CP, Wirtz-Brugger F, Giovanni A. Amyloid beta-peptides inhibit Na+\/K+-ATPase: tissue slices versus primary cultures. Brain Res Bull. 1998;46(5):423\u20137. https:\/\/doi.org\/10.1016\/s0361-9230(97)00382-1.","journal-title":"Brain Res Bull"},{"issue":"3","key":"717_CR58","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF02800498","volume":"9","author":"NB Chauhan","year":"1997","unstructured":"Chauhan NB, Lee JM, Siegel GJ. Na,K-ATPase mRNA levels and plaque load in Alzheimer\u2019s disease. J Mol Neurosci. 1997;9(3):151\u201366. https:\/\/doi.org\/10.1007\/BF02800498.","journal-title":"J Mol Neurosci"},{"issue":"11","key":"717_CR59","doi-asserted-by":"publisher","first-page":"5900","DOI":"10.3390\/ijms22115900","volume":"22","author":"PP Guan","year":"2021","unstructured":"Guan PP, Cao LL, Wang P. Elevating the levels of calcium ions exacerbate Alzheimer\u2019s disease via inducing the production and aggregation of \u03b2-Amyloid protein and phosphorylated Tau. Int J Mol Sci. 2021;22(11):5900. https:\/\/doi.org\/10.3390\/ijms22115900.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"717_CR60","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.pneurobio.2012.03.002","volume":"99","author":"M Stefani","year":"2012","unstructured":"Stefani M. Structural features and cytotoxicity of amyloid oligomers: implications in Alzheimer\u2019s disease and other diseases with amyloid deposits. Prog Neurobiol. 2012;99(3):226\u201345. https:\/\/doi.org\/10.1016\/j.pneurobio.2012.03.002.","journal-title":"Prog Neurobiol"},{"issue":"3","key":"717_CR61","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.conb.2012.01.007","volume":"22","author":"DL Hunt","year":"2012","unstructured":"Hunt DL, Castillo PE. Synaptic plasticity of NMDA receptors: mechanisms and functional implications. Curr Opin Neurobiol. 2012;22(3):496\u2013508. https:\/\/doi.org\/10.1016\/j.conb.2012.01.007.","journal-title":"Curr Opin Neurobiol"},{"issue":"3","key":"717_CR62","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.neurobiolaging.2013.08.031","volume":"35","author":"Y Deng","year":"2014","unstructured":"Deng Y, Xiong Z, Chen P, Wei J, Chen S, Yan Z. \u03b2-amyloid impairs the regulation of N-methyl-D-aspartate receptors by glycogen synthase kinase 3. Neurobiol Aging. 2014;35(3):449\u201359. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.08.031.","journal-title":"Neurobiol Aging"},{"issue":"7","key":"717_CR63","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1523\/JNEUROSCI.4456-09.2010","volume":"30","author":"HY Wu","year":"2010","unstructured":"Wu HY, Hudry E, Hashimoto T, Kuchibhotla K, Rozkalne A, Fan Z, et al. Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation. J Neurosci. 2010;30(7):2636\u201349. https:\/\/doi.org\/10.1523\/JNEUROSCI.4456-09.2010.","journal-title":"J Neurosci"},{"key":"717_CR64","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-025-01672-7","author":"A Awasthi","year":"2025","unstructured":"Awasthi A, Maparu K, Singh S. Ferroptosis role in complexity of cell death: unrevealing mechanisms in Parkinson\u2019s disease and therapeutic approaches. Inflammopharmacol. 2025. https:\/\/doi.org\/10.1007\/s10787-025-01672-7.","journal-title":"Inflammopharmacol"},{"key":"717_CR65","doi-asserted-by":"publisher","unstructured":"Kouli A, Torsney KM, Kuan WL. Parkinson\u2019s Disease: Etiology, Neuropathology, and Pathogenesis. In: Stoker TB, Greenland JC, editors. Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects [Internet]. Brisbane (AU): Codon Publications; 2018 Dec 21. Chapter 1. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK536722\/https:\/\/doi.org\/10.15586\/codonpublications.parkinsonsdisease.2018.ch1","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch1"},{"issue":"7","key":"717_CR66","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/humu.21277","volume":"31","author":"K Nuytemans","year":"2010","unstructured":"Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C. Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum Mutat. 2010;31(7):763\u201380. https:\/\/doi.org\/10.1002\/humu.21277.","journal-title":"Hum Mutat"},{"issue":"2","key":"717_CR67","doi-asserted-by":"publisher","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L. \u03b1-Synuclein in Parkinson\u2019s disease. Cold Spring Harb Perspect Med. 2012;2(2):a009399. https:\/\/doi.org\/10.1101\/cshperspect.a009399.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"717_CR68","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.neuron.2004.06.028","volume":"43","author":"P de Carvalho Aguiar","year":"2004","unstructured":"de Carvalho Aguiar P, Sweadner KJ, Penniston JT, Zaremba J, Liu L, Caton M, et al. Mutations in the Na+\/K+ -ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron. 2004;43(2):169\u201375. https:\/\/doi.org\/10.1016\/j.neuron.2004.06.028.","journal-title":"Neuron"},{"issue":"Suppl 1","key":"717_CR69","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/jnc.13593","volume":"139","author":"DG Hernandez","year":"2016","unstructured":"Hernandez DG, Reed X, Singleton AB. Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance. J Neurochem. 2016;139(Suppl 1):59\u201374. https:\/\/doi.org\/10.1111\/jnc.13593.","journal-title":"J Neurochem"},{"key":"717_CR70","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fphys.2016.00209","volume":"7","author":"TH Holm","year":"2016","unstructured":"Holm TH, Lykke-Hartmann K. Insights into the pathology of the \u03913 Na(+)\/K(+)-ATPase ion pump in neurological disorders; lessons from animal models. Front Physiol. 2016;7:209. https:\/\/doi.org\/10.3389\/fphys.2016.00209.","journal-title":"Front Physiol"},{"issue":"3","key":"717_CR71","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1523\/JNEUROSCI.4464-06.2007","volume":"27","author":"AE Moseley","year":"2007","unstructured":"Moseley AE, Williams MT, Schaefer TL, Bohanan CS, Neumann JC, Behbehani MM, et al. Deficiency in Na,K-ATPase alpha isoform genes alters Spatial learning, motor activity, and anxiety in mice. J Neurosci. 2007;27(3):616\u201326. https:\/\/doi.org\/10.1523\/JNEUROSCI.4464-06.2007.","journal-title":"J Neurosci"},{"issue":"15","key":"717_CR72","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.3390\/cells13151301","volume":"13","author":"G Bastioli","year":"2024","unstructured":"Bastioli G, Piccirillo S, Graciotti L, Carone M, Sprega G, Taoussi O, et al. Calcium deregulation in neurodegeneration and neuroinflammation in Parkinson\u2019s disease: role of Calcium-Storing organelles and Sodium-Calcium exchanger. Cells. 2024;13(15):1301. https:\/\/doi.org\/10.3390\/cells13151301.","journal-title":"Cells"},{"issue":"5","key":"717_CR73","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S1474-4422(14)70011-0","volume":"13","author":"EL Heinzen","year":"2014","unstructured":"Heinzen EL, Arzimanoglou A, Brashear A, Clapcote SJ, Gurrieri F, Goldstein DB, et al. Distinct neurological disorders with ATP1A3 mutations. Lancet Neurol. 2014;13(5):503\u201314. https:\/\/doi.org\/10.1016\/S1474-4422(14)70011-0.","journal-title":"Lancet Neurol"},{"issue":"7","key":"717_CR74","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.3390\/biomedicines11071820","volume":"11","author":"AA Markina","year":"2023","unstructured":"Markina AA, Kazanskaya RB, Timoshina JA, Zavialov VA, Abaimov DA, Volnova AB, et al. Na+,K+-ATPase and cardiotonic steroids in models of dopaminergic system pathologies. Biomedicines. 2023;11(7):1820. https:\/\/doi.org\/10.3390\/biomedicines11071820.","journal-title":"Biomedicines"},{"issue":"3","key":"717_CR75","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00109-021-02143-6","volume":"100","author":"M Zhu","year":"2022","unstructured":"Zhu M, Sun H, Cao L, Wu Z, Leng B, Bian J. Role of Na+\/K+-ATPase in ischemic stroke: in-depth perspectives from physiology to Pharmacology. J Mol Med (Berl). 2022;100(3):395\u2013410. https:\/\/doi.org\/10.1007\/s00109-021-02143-6.","journal-title":"J Mol Med (Berl)"},{"issue":"10","key":"717_CR76","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1089\/ars.2010.3208","volume":"14","author":"CA Massaad","year":"2011","unstructured":"Massaad CA, Klann E. Reactive oxygen species in the regulation of synaptic plasticity and memory. Antioxid Redox Signal. 2011;14(10):2013\u201354. https:\/\/doi.org\/10.1089\/ars.2010.3208.","journal-title":"Antioxid Redox Signal"},{"issue":"19","key":"717_CR77","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.15252\/embj.201591397","volume":"34","author":"AN Shrivastava","year":"2015","unstructured":"Shrivastava AN, Redeker V, Fritz N, Pieri L, Almeida LG, Spolidoro M, et al. \u03b1-synuclein assemblies sequester neuronal \u03b13-Na+\/K+-ATPase and impair Na\u2009+\u2009gradient. EMBO J. 2015;34(19):2408\u201323. https:\/\/doi.org\/10.15252\/embj.201591397.","journal-title":"EMBO J"},{"issue":"1","key":"717_CR78","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3892\/br.2022.1587","volume":"18","author":"AM Palaiogeorgou","year":"2022","unstructured":"Palaiogeorgou AM, Papakonstantinou E, Golfinopoulou R, Sigala M, Mitsis T, Papageorgiou L, et al. Recent approaches on Huntington\u2019s disease (Review). Biomed Rep. 2022;18(1):5. https:\/\/doi.org\/10.3892\/br.2022.1587.","journal-title":"Biomed Rep"},{"issue":"10","key":"717_CR79","doi-asserted-by":"publisher","first-page":"e47526","DOI":"10.7759\/cureus.47526","volume":"15","author":"H Dhingra","year":"2023","unstructured":"Dhingra H, Gaidhane SA. Huntington\u2019s disease: Understanding its novel drugs and treatments. Cureus. 2023;15(10):e47526. https:\/\/doi.org\/10.7759\/cureus.47526.","journal-title":"Cureus"},{"issue":"10","key":"717_CR80","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3390\/brainsci12101389","volume":"12","author":"Z Irfan","year":"2022","unstructured":"Irfan Z, Khanam S, Karmakar V, Firdous SM, El Khier BSIA, Khan I, et al. Pathogenesis of Huntington\u2019s disease: an emphasis on molecular pathways and prevention by natural remedies. Brain Sci. 2022;12(10):1389. https:\/\/doi.org\/10.3390\/brainsci12101389.","journal-title":"Brain Sci"},{"issue":"16","key":"717_CR81","doi-asserted-by":"publisher","first-page":"13021","DOI":"10.3390\/ijms241613021","volume":"24","author":"A Jiang","year":"2023","unstructured":"Jiang A, Handley RR, Lehnert K, Snell RG. From pathogenesis to therapeutics: A review of 150 years of Huntington\u2019s disease research. Int J Mol Sci. 2023;24(16):13021. https:\/\/doi.org\/10.3390\/ijms241613021.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"717_CR82","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1471-4159.1984.tb00931.x","volume":"43","author":"F Schroeder","year":"1984","unstructured":"Schroeder F, Goetz IE, Roberts E. Membrane anomalies in Huntington\u2019s disease fibroblasts. J Neurochem. 1984;43(2):526\u201339. https:\/\/doi.org\/10.1111\/j.1471-4159.1984.tb00931.x.","journal-title":"J Neurochem"},{"issue":"3","key":"717_CR83","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.arcmed.2007.11.011","volume":"39","author":"AM Estrada S\u00e1nchez","year":"2008","unstructured":"Estrada S\u00e1nchez AM, Mej\u00eda-Toiber J, Massieu L. Excitotoxic neuronal death and the pathogenesis of Huntington\u2019s disease. Arch Med Res. 2008;39(3):265\u201376. https:\/\/doi.org\/10.1016\/j.arcmed.2007.11.011.","journal-title":"Arch Med Res"},{"issue":"12","key":"717_CR84","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.4103\/NRR.NRR-D-23-01175","volume":"19","author":"S Huang","year":"2024","unstructured":"Huang S, Dong W, Lin X, Bian J. Na+\/K+-ATPase: ion pump, signal transducer, or cytoprotective protein, and novel biological functions. Neural Regen Res. 2024;19(12):2684\u201397. https:\/\/doi.org\/10.4103\/NRR.NRR-D-23-01175.","journal-title":"Neural Regen Res"},{"issue":"11","key":"717_CR85","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/BF00964997","volume":"8","author":"VA Russell","year":"1983","unstructured":"Russell VA, Lamm MC, Taljaard JJ. Inhibition of Na+, K+-ATPase activity by delta-aminolevulinic acid. Neurochem Res. 1983;8(11):1407\u201315. https:\/\/doi.org\/10.1007\/BF00964997.","journal-title":"Neurochem Res"},{"issue":"2","key":"717_CR86","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/antiox12020433","volume":"12","author":"NK Isaev","year":"2023","unstructured":"Isaev NK, Genrikhs EE, Stelmashook EV. Antioxidant thymoquinone and its potential in the treatment of neurological diseases. Antioxid (Basel). 2023;12(2):433. https:\/\/doi.org\/10.3390\/antiox12020433.","journal-title":"Antioxid (Basel)"},{"key":"717_CR87","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/s41380-023-01949-9","volume":"28","author":"RA McCutcheon","year":"2023","unstructured":"McCutcheon RA, Keefe RSE, McGuire PK. Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment. Mol Psychiatry. 2023;28:1902\u201318. https:\/\/doi.org\/10.1038\/s41380-023-01949-9.","journal-title":"Mol Psychiatry"},{"key":"717_CR88","unstructured":"Hany M, Rehman B, Rizvi A, Chapman J. Schizophrenia. [Updated 2024 Feb 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK539864\/"},{"key":"717_CR89","doi-asserted-by":"publisher","unstructured":"Fernandez-Egea E, Jones PB. Schizophrenia. In: Lynall M-E, Jones PB, Stahl SM, editors. Cambridge textbook of neuroscience for psychiatrists. Cambridge University Press; 2023. pp. 467\u201376. https:\/\/doi.org\/10.1017\/9781911623137.065.","DOI":"10.1017\/9781911623137.065"},{"issue":"1","key":"717_CR90","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/wps.20693","volume":"19","author":"RA McCutcheon","year":"2020","unstructured":"McCutcheon RA, Krystal JH, Howes OD. Dopamine and glutamate in schizophrenia: biology, symptoms and treatment. World Psychiatry. 2020;19(1):15\u201333. https:\/\/doi.org\/10.1002\/wps.20693.","journal-title":"World Psychiatry"},{"issue":"Suppl 3","key":"717_CR91","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.1093\/schbul\/sbu006","volume":"40","author":"WW Fleischhacker","year":"2014","unstructured":"Fleischhacker WW, Arango C, Arteel P, Barnes TR, Carpenter W, Duckworth K, et al. Schizophrenia\u2013time to commit to policy change. Schizophr Bull. 2014;40(Suppl 3):S165\u201394. https:\/\/doi.org\/10.1093\/schbul\/sbu006.","journal-title":"Schizophr Bull"},{"key":"717_CR92","doi-asserted-by":"publisher","unstructured":"Roy S, Dasgupta A, Banerjee U, Chowdhury P, Mukhopadhyay A, Saha G et al. Role of membrane cholesterol and lipid peroxidation in regulating the Na+\/K+-ATPase activity in schizophrenia. Indian J Psychiatry 2016 Jul-Sep;58(3):317\u201325. https:\/\/doi.org\/10.4103\/0019-5545.192023","DOI":"10.4103\/0019-5545.192023"},{"key":"717_CR93","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.neuroscience.2020.07.009","volume":"442","author":"CA Lowry","year":"2020","unstructured":"Lowry CA, Golod ME, Andrew RD, Bennett BM. Expression of neuronal Na+\/K+-ATPase \u03b1 subunit isoforms in the mouse brain following genetically programmed or Behaviourally-induced oxidative stress. Neuroscience. 2020;442:202\u201315. https:\/\/doi.org\/10.1016\/j.neuroscience.2020.07.009.","journal-title":"Neuroscience"},{"issue":"9","key":"717_CR94","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.bbamem.2015.03.012","volume":"1848","author":"F Cornelius","year":"2015","unstructured":"Cornelius F, Habeck M, Kanai R, Toyoshima C, Karlish SJ. General and specific lipid-protein interactions in Na,K-ATPase. Biochim Biophys Acta. 2015;1848(9):1729\u201343. https:\/\/doi.org\/10.1016\/j.bbamem.2015.03.012.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"717_CR95","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1046\/j.1528-1157.2003.42902.x","volume":"44","author":"CR Malfatti","year":"2003","unstructured":"Malfatti CR, Royes LF, Francescato L, Sanabria ER, Rubin MA, Cavalheiro EA, et al. Intrastriatal methylmalonic acid administration induces convulsions and TBARS production, and alters Na+,K+-ATPase activity in the rat striatum and cerebral cortex. Epilepsia. 2003;44(6):761\u20137. https:\/\/doi.org\/10.1046\/j.1528-1157.2003.42902.x.","journal-title":"Epilepsia"},{"issue":"3","key":"717_CR96","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.neubiorev.2010.10.008","volume":"35","author":"BK Bitanihirwe","year":"2011","unstructured":"Bitanihirwe BK, Woo TU. Oxidative stress in schizophrenia: an integrated approach. Neurosci Biobehav Rev. 2011;35(3):878\u201393. https:\/\/doi.org\/10.1016\/j.neubiorev.2010.10.008.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"717_CR97","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3109\/10641963.2013.783048","volume":"36","author":"R Rodrigo","year":"2014","unstructured":"Rodrigo R, Miranda-Merchak A, Valenzuela Grau R, Bachler JP, Vergara L. Modulation of (Na,K)-ATPase activity by membrane fatty acid composition: therapeutic implications in human hypertension. Clin Exp Hypertens. 2014;36(1):17\u201326. https:\/\/doi.org\/10.3109\/10641963.2013.783048.","journal-title":"Clin Exp Hypertens"},{"issue":"11","key":"717_CR98","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00114-003-0470-z","volume":"90","author":"N Turner","year":"2003","unstructured":"Turner N, Else PL, Hulbert AJ. Docosahexaenoic acid (DHA) content of membranes determines molecular activity of the sodium pump: implications for disease States and metabolism. Die Naturwiss. 2003;90(11):521\u20133. https:\/\/doi.org\/10.1007\/s00114-003-0470-z.","journal-title":"Die Naturwiss"},{"issue":"3","key":"717_CR99","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/nu8030128","volume":"8","author":"AP Simopoulos","year":"2016","unstructured":"Simopoulos AP. An increase in the Omega-6\/Omega-3 fatty acid ratio increases the risk for obesity. Nutrients. 2016;8(3):128. https:\/\/doi.org\/10.3390\/nu8030128.","journal-title":"Nutrients"},{"key":"717_CR100","doi-asserted-by":"publisher","unstructured":"Baum SJ, Kris-Etherton PM, Willett WC, Lichtenstein AH, Rudel LL, Maki KC et al. Fatty acids in cardiovascular health and disease: a comprehensive update. J Clin Lipidol 2012 May-Jun;6(3):216\u201334. https:\/\/doi.org\/10.1016\/j.jacl.2012.04.077","DOI":"10.1016\/j.jacl.2012.04.077"},{"key":"717_CR101","doi-asserted-by":"publisher","unstructured":"Joy CB, Mumby-Croft R, Joy LA. Polyunsaturated fatty acid supplementation for schizophrenia. Cochrane Database Syst Rev. 2003;2CD001257. https:\/\/doi.org\/10.1002\/14651858.CD001257.","DOI":"10.1002\/14651858.CD001257"},{"issue":"1","key":"717_CR102","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12944-020-01337-0","volume":"19","author":"MC Hsu","year":"2020","unstructured":"Hsu MC, Huang YS, Ouyang WC. Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms. Lipids Health Dis. 2020;19(1):159. https:\/\/doi.org\/10.1186\/s12944-020-01337-0.","journal-title":"Lipids Health Dis"},{"issue":"1\u20133","key":"717_CR103","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.schres.2011.01.021","volume":"128","author":"C Corti","year":"2011","unstructured":"Corti C, Xuereb JH, Crepaldi L, Corsi M, Michielin F, Ferraguti F. Altered levels of glutamatergic receptors and Na+\/K\u2009+\u2009ATPase-\u03b11 in the prefrontal cortex of subjects with schizophrenia. Schizophr Res. 2011;128(1\u20133):7\u201314. https:\/\/doi.org\/10.1016\/j.schres.2011.01.021.","journal-title":"Schizophr Res"},{"key":"717_CR104","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cbpa.2015.07.018","volume":"189","author":"MJ Lan\u00e7a","year":"2015","unstructured":"Lan\u00e7a MJ, Machado M, Ferreira AF, Quintella BR, de Almeida PR. Structural lipid changes and Na(+)\/K(+)-ATPase activity of gill cells\u2019 basolateral membranes during saltwater acclimation in sea lamprey (Petromyzon Marinus, L.) juveniles. Comp Biochem Physiol Mol Integr Physiol. 2015;189:67\u201375. https:\/\/doi.org\/10.1016\/j.cbpa.2015.07.018.","journal-title":"Comp Biochem Physiol Mol Integr Physiol"},{"issue":"1","key":"717_CR105","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1152\/jn.00481.2016","volume":"117","author":"A Kassan","year":"2017","unstructured":"Kassan A, Egawa J, Zhang Z, Almenar-Queralt A, Nguyen QM, Lajevardi Y, et al. Caveolin-1 regulation of disrupted-in-schizophrenia-1 as a potential therapeutic target for schizophrenia. J Neurophysiol. 2017;117(1):436\u201344. https:\/\/doi.org\/10.1152\/jn.00481.2016.","journal-title":"J Neurophysiol"},{"key":"717_CR106","doi-asserted-by":"publisher","unstructured":"Chatterjee D, Maparu K, Singh S. Exploring pathological targets and advancing pharmacotherapy in autism spectrum disorder: contributions of glial cells and heavy metals. Histol Histopathol 2025 Jan 3:18870. https:\/\/doi.org\/10.14670\/HH-18-870","DOI":"10.14670\/HH-18-870"},{"key":"717_CR107","unstructured":"Hodis B, Mughal S, Saadabadi A. Autism Spectrum Disorder. [Updated 2025 Jan 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK525976\/"},{"key":"717_CR108","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3389\/fncel.2019.00385","volume":"13","author":"L Rylaarsdam","year":"2019","unstructured":"Rylaarsdam L, Guemez-Gamboa A. Genetic causes and modifiers of autism spectrum disorder. Front Cell Neurosci. 2019;13:385. https:\/\/doi.org\/10.3389\/fncel.2019.00385.","journal-title":"Front Cell Neurosci"},{"key":"717_CR109","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev-med-120417-091431","volume":"70","author":"MW Tremblay","year":"2019","unstructured":"Tremblay MW, Jiang YH. DNA methylation and susceptibility to autism spectrum disorder. Annu Rev Med. 2019;70:151\u201366. https:\/\/doi.org\/10.1146\/annurev-med-120417-091431.","journal-title":"Annu Rev Med"},{"key":"717_CR110","doi-asserted-by":"publisher","first-page":"781327","DOI":"10.3389\/fcell.2021.781327","volume":"9","author":"H Zhao","year":"2022","unstructured":"Zhao H, Mao X, Zhu C, Zou X, Peng F, Yang W, Li B, Li G, Ge T, Cui R. GABAergic system dysfunction in autism spectrum disorders. Front Cell Dev Biol. 2022;9:781327. https:\/\/doi.org\/10.3389\/fcell.2021.781327.","journal-title":"Front Cell Dev Biol"},{"issue":"Mar\u2013Apr","key":"717_CR111","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ntt.2012.07.006","volume":"36","author":"Goines PE","year":"2013","unstructured":"Goines PE, Ashwood P. Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. Neurotoxicol Teratol. 2013;36(Mar\u2013Apr):67\u201381. https:\/\/doi.org\/10.1016\/j.ntt.2012.07.006.","journal-title":"Neurotoxicol Teratol"},{"issue":"2","key":"717_CR112","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/ph11020056","volume":"11","author":"D Siniscalco","year":"2018","unstructured":"Siniscalco D, Schultz S, Brigida AL, Antonucci N. Inflammation and Neuro-Immune dysregulations in autism spectrum disorders. Pharmaceuticals (Basel). 2018;11(2):56. https:\/\/doi.org\/10.3390\/ph11020056.","journal-title":"Pharmaceuticals (Basel)"},{"key":"717_CR113","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3389\/fphys.2016.00195","volume":"7","author":"PF Kinoshita","year":"2016","unstructured":"Kinoshita PF, Leite JA, Orellana AM, Vasconcelos AR, Quintas LE, Kawamoto EM, et al. The influence of Na(+), K(+)-ATPase on glutamate signaling in neurodegenerative diseases and senescence. Front Physiol. 2016;7:195. https:\/\/doi.org\/10.3389\/fphys.2016.00195.","journal-title":"Front Physiol"},{"issue":"1","key":"717_CR114","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12916-024-03617-3","volume":"22","author":"C Love","year":"2024","unstructured":"Love C, Sominsky L, O\u2019Hely M, Berk M, Vuillermin P, Dawson SL. Prenatal environmental risk factors for autism spectrum disorder and their potential mechanisms. BMC Med. 2024;22(1):393. https:\/\/doi.org\/10.1186\/s12916-024-03617-3.","journal-title":"BMC Med"},{"issue":"2","key":"717_CR115","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/jpm11020070","volume":"11","author":"C Panisi","year":"2021","unstructured":"Panisi C, Guerini FR, Abruzzo PM, Balzola F, Biava PM, Bolotta A, et al. Autism spectrum disorder from the womb to adulthood: suggestions for a paradigm shift. J Pers Med. 2021;11(2):70. https:\/\/doi.org\/10.3390\/jpm11020070.","journal-title":"J Pers Med"},{"issue":"10","key":"717_CR116","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/aur.2002","volume":"11","author":"A Bolotta","year":"2018","unstructured":"Bolotta A, Visconti P, Fedrizzi G, Ghezzo A, Marini M, Manunta P, et al. Na+, K+ -ATPase activity in children with autism spectrum disorder: searching for the reason(s) of its decrease in blood cells. Autism Res. 2018;11(10):1388\u2013403. https:\/\/doi.org\/10.1002\/aur.2002.","journal-title":"Autism Res"},{"key":"717_CR117","doi-asserted-by":"publisher","first-page":"102851doi","DOI":"10.1016\/j.ceca.2024.102851","volume":"118","author":"D Pietrobon","year":"2024","unstructured":"Pietrobon D, Conti F. Astrocytic Na+, K+ ATPases in physiology and pathophysiology. Cell Calcium. 2024;118:102851doi. https:\/\/doi.org\/10.1016\/j.ceca.2024.102851.","journal-title":"Cell Calcium"},{"key":"717_CR118","doi-asserted-by":"publisher","first-page":"149472","DOI":"10.1016\/j.brainres.2025.149472","volume":"1851","author":"A Kaur","year":"2025","unstructured":"Kaur A, Rohit, Aran KR. Unraveling the dual role of bilirubin in neurological diseases: A comprehensive exploration of its neuroprotective and neurotoxic effects. Brain Res. 2025;1851:149472. https:\/\/doi.org\/10.1016\/j.brainres.2025.149472.","journal-title":"Brain Res"},{"key":"717_CR119","doi-asserted-by":"publisher","first-page":"106949","DOI":"10.1016\/j.yebeh.2020.106949","volume":"105","author":"G Singh","year":"2020","unstructured":"Singh G, Sander JW. The global burden of epilepsy report: implications for low- and middle-income countries. Epilepsy Behav. 2020;105:106949. https:\/\/doi.org\/10.1016\/j.yebeh.2020.106949.","journal-title":"Epilepsy Behav"},{"key":"717_CR120","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.seizure.2023.09.021","volume":"116","author":"MW Zhang","year":"2024","unstructured":"Zhang MW, Liang XY, Wang J, Gao LD, Liao HJ, He YH, et al. Epilepsy-associated genes: an update. Seizure. 2024;116:4\u201313. https:\/\/doi.org\/10.1016\/j.seizure.2023.09.021.","journal-title":"Seizure"},{"key":"717_CR121","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1017\/gmh.2016.11","volume":"3","author":"H Stuart","year":"2016","unstructured":"Stuart H. Reducing the stigma of mental illness. Glob Ment Health (Camb). 2016;3:e17. https:\/\/doi.org\/10.1017\/gmh.2016.11.","journal-title":"Glob Ment Health (Camb)"},{"issue":"9","key":"717_CR122","doi-asserted-by":"publisher","first-page":"e10549","DOI":"10.7759\/cureus.10549","volume":"12","author":"ST Sarmast","year":"2020","unstructured":"Sarmast ST, Abdullahi AM, Jahan N. Current classification of seizures and epilepsies: scope, limitations and recommendations for future action. Cureus. 2020;12(9):e10549. https:\/\/doi.org\/10.7759\/cureus.10549.","journal-title":"Cureus"},{"issue":"3","key":"717_CR123","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1124\/pr.120.019539","volume":"72","author":"W L\u00f6scher","year":"2020","unstructured":"L\u00f6scher W, Potschka H, Sisodiya SM, Vezzani A. Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options. Pharmacol Rev. 2020;72(3):606\u201338. https:\/\/doi.org\/10.1124\/pr.120.019539.","journal-title":"Pharmacol Rev"},{"key":"717_CR124","doi-asserted-by":"publisher","first-page":"657256","DOI":"10.3389\/fped.2021.657256","volume":"9","author":"Z Lin","year":"2021","unstructured":"Lin Z, Li J, Ji T, Wu Y, Gao K, Jiang Y. ATP1A1 de Novo Mutation-Related disorders: clinical and genetic features. Front Pediatr. 2021;9:657256. https:\/\/doi.org\/10.3389\/fped.2021.657256.","journal-title":"Front Pediatr"},{"issue":"5","key":"717_CR125","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ajhg.2018.10.004","volume":"103","author":"KP Schlingmann","year":"2018","unstructured":"Schlingmann KP, Bandulik S, Mammen C, Tarailo-Graovac M, Holm R, Baumann M, et al. Germline de Novo mutations in ATP1A1 cause renal hypomagnesemia, refractory seizures, and intellectual disability. Am J Hum Genet. 2018;103(5):808\u201316. https:\/\/doi.org\/10.1016\/j.ajhg.2018.10.004.","journal-title":"Am J Hum Genet"},{"key":"717_CR126","doi-asserted-by":"publisher","first-page":"648031","DOI":"10.3389\/fneur.2021.648031","volume":"12","author":"CM de Gusm\u00e3o","year":"2021","unstructured":"de Gusm\u00e3o CM, Garcia L, Mikati MA, Su S, Silveira-Moriyama L. Paroxysmal genetic movement disorders and epilepsy. Front Neurol. 2021;12:648031. https:\/\/doi.org\/10.3389\/fneur.2021.648031.","journal-title":"Front Neurol"},{"issue":"3","key":"717_CR127","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/ana.10674","volume":"54","author":"KR Vanmolkot","year":"2003","unstructured":"Vanmolkot KR, Kors EE, Hottenga JJ, Terwindt GM, Haan J, Hoefnagels WA, et al. Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with Familial hemiplegic migraine and benign Familial infantile convulsions. Ann Neurol. 2003;54(3):360\u20136. https:\/\/doi.org\/10.1002\/ana.10674.","journal-title":"Ann Neurol"},{"key":"717_CR128","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fphys.2016.00239","volume":"7","author":"T Friedrich","year":"2016","unstructured":"Friedrich T, Tavraz NN, Junghans C. ATP1A2 mutations in migraine: seeing through the facets of an ion pump onto the neurobiology of disease. Front Physiol. 2016;7:239. https:\/\/doi.org\/10.3389\/fphys.2016.00239.","journal-title":"Front Physiol"},{"issue":"1","key":"717_CR129","doi-asserted-by":"publisher","first-page":"fcaa221","DOI":"10.1093\/braincomms\/fcaa221","volume":"3","author":"A Chloe","year":"2021","unstructured":"Chloe A, Stutterd S, Brock K, Stouffs M, Fanjul-Fernandez PJ, Lockhart G, McGillivray, et al. Genetic heterogeneity of polymicrogyria: study of 123 patients using deep sequencing. Brain Commun. 2021;3(1):fcaa221. https:\/\/doi.org\/10.1093\/braincomms\/fcaa221.","journal-title":"Brain Commun"},{"issue":"11","key":"717_CR130","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1093\/brain\/awz272","volume":"142","author":"N Chatron","year":"2019","unstructured":"Chatron N, Cabet S, Alix E, Buenerd A, Cox P, Guibaud L, Labalme A, Marks P, Osio D, Putoux A, Sanlaville D, Lesca G, Vasiljevic A. A novel lethal recognizable polymicrogyric syndrome caused by ATP1A2 homozygous truncating variants. Brain. 2019;142(11):3367\u201374. https:\/\/doi.org\/10.1093\/brain\/awz272.","journal-title":"Brain"},{"key":"717_CR131","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jocn.2020.01.041","volume":"72","author":"M Gasser","year":"2020","unstructured":"Gasser M, Boonsimma P, Netbaramee W, Wechapinan T, Srichomthomg C, Ittiwut C, et al. ATP1A3-related epilepsy: report of seven cases and literature-based analysis of treatment response. J Clin Neurosci. 2020;72:31\u20138. https:\/\/doi.org\/10.1016\/j.jocn.2020.01.041.","journal-title":"J Clin Neurosci"},{"issue":"5","key":"717_CR132","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S1474-4422(14)70011-0","volume":"13","author":"EL Markina","year":"2014","unstructured":"Markina EL, Arzimanoglou A, Brashear A, Clapcote SJ, Gurrieri F, Goldstein DB, ATP1A3 Working Group, et al. Distinct neurological disorders with ATP1A3 mutations. Lancet Neurol. 2014;13(5):503\u201314. https:\/\/doi.org\/10.1016\/S1474-4422(14)70011-0.","journal-title":"Lancet Neurol"},{"issue":"3","key":"717_CR133","doi-asserted-by":"publisher","first-page":"e0015","DOI":"10.5041\/RMMJ.10529","volume":"15","author":"JP Rissardo","year":"2024","unstructured":"Rissardo JP, Vora NM, Singh Y, Kishore S, Caprara ALF. Navigating the complexity of alternating hemiplegia in childhood: A comprehensive review. Rambam Maimonides Med J. 2024;15(3):e0015. https:\/\/doi.org\/10.5041\/RMMJ.10529.","journal-title":"Rambam Maimonides Med J"},{"issue":"3","key":"717_CR134","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.braindev.2018.10.008","volume":"41","author":"N Ishihara","year":"2019","unstructured":"Ishihara N, Inagaki H, Miyake M, Kawamura Y, Yoshikawa T, Kurahashi H. A case of early onset life-threatening epilepsy associated with a novel ATP1A3 gene variant. Brain Dev. 2019;41(3):285\u201391. https:\/\/doi.org\/10.1016\/j.braindev.2018.10.008.","journal-title":"Brain Dev"},{"key":"717_CR135","doi-asserted-by":"publisher","unstructured":"Shimada T, Yamagata K. Pentylenetetrazole-Induced kindling mouse model. J Vis Exp. 2018;13656573. https:\/\/doi.org\/10.3791\/56573.","DOI":"10.3791\/56573"},{"issue":"3","key":"717_CR136","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.eplepsyres.2013.03.007","volume":"105","author":"BP Marquezan","year":"2013","unstructured":"Marquezan BP, Funck VR, Oliveira CV, Pereira LM, Ara\u00fajo SM, Zarzecki MS, et al. Pentylenetetrazol-induced seizures are associated with Na\u207a,K\u207a-ATPase activity decrease and alpha subunit phosphorylation state in the mice cerebral cortex. Epilepsy Res. 2013;105(3):396\u2013400. https:\/\/doi.org\/10.1016\/j.eplepsyres.2013.03.007.","journal-title":"Epilepsy Res"},{"issue":"2","key":"717_CR137","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/jnr.490290211","volume":"29","author":"D Guillaume","year":"1991","unstructured":"Guillaume D, Grisar T, Delgado-Escueta AV, Bureau-Heeren M, Laschet J. Phosphorylation of brain (Na+,K+)-ATPase alpha Catalytic subunits in normal and epileptic cerebral cortex: I. The audiogenic mice and the Cat with a freeze lesion. J Neurosci Res. 1991;29(2):207\u201317. https:\/\/doi.org\/10.1002\/jnr.490290211.","journal-title":"J Neurosci Res"},{"key":"717_CR138","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fncir.2013.00188","volume":"7","author":"AM W\u00f3jtowicz","year":"2013","unstructured":"W\u00f3jtowicz AM, Dvorzhak A, Semtner M, Grantyn R. Reduced tonic Inhibition in striatal output neurons from huntington mice due to loss of astrocytic GABA release through GAT-3. Front Neural Circuits. 2013;7:188. https:\/\/doi.org\/10.3389\/fncir.2013.00188.","journal-title":"Front Neural Circuits"},{"key":"717_CR139","doi-asserted-by":"publisher","first-page":"114786","DOI":"10.1016\/j.bcp.2021.114786","volume":"193","author":"JL Green","year":"2021","unstructured":"Green JL, Dos Santos WF, Fontana ACK. Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: opportunities for novel therapeutics development. Biochem Pharmacol. 2021;193:114786. https:\/\/doi.org\/10.1016\/j.bcp.2021.114786.","journal-title":"Biochem Pharmacol"},{"issue":"21","key":"717_CR140","doi-asserted-by":"publisher","first-page":"jcs222570","DOI":"10.1242\/jcs.222570","volume":"132","author":"J Condon K","year":"2019","unstructured":"Condon J K., Sabatini M D. Nutrient regulation of mTORC1 at a glance. J Cell Sci. 2019;132(21):jcs222570. https:\/\/doi.org\/10.1242\/jcs.222570.","journal-title":"J Cell Sci"},{"issue":"45","key":"717_CR141","doi-asserted-by":"publisher","first-page":"15704","DOI":"10.1523\/JNEUROSCI.2392-12.2012","volume":"32","author":"J McMahon","year":"2012","unstructured":"McMahon J, Huang X, Yang J, Komatsu M, Yue Z, Qian J, et al. Impaired autophagy in neurons after disinhibition of mammalian target of Rapamycin and its contribution to epileptogenesis. J Neurosci. 2012;32(45):15704\u201314. https:\/\/doi.org\/10.1523\/JNEUROSCI.2392-12.2012.","journal-title":"J Neurosci"},{"key":"717_CR142","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00401-013-1135-4","volume":"126","author":"SA Yasin","year":"2013","unstructured":"Yasin SA, Ali AM, Tata M, Picker SR, Anderson GW, Latimer-Bowman E, et al. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis. Acta Neuropathol. 2013;126:207\u201318. https:\/\/doi.org\/10.1007\/s00401-013-1135-4.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"717_CR143","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-020-0153-7","volume":"5","author":"M Zhu","year":"2020","unstructured":"Zhu M, Cao L, Xiong S, Sun H, Wu Z, Bian JS. Na+\/K+-ATPase-dependent autophagy protects brain against ischemic injury. Signal Transduct Target Ther. 2020;5(1):55. https:\/\/doi.org\/10.1038\/s41392-020-0153-7.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"717_CR144","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3390\/molecules22040578","volume":"22","author":"C Felippe Gon\u00e7alves-de-Albuquerque","year":"2017","unstructured":"Felippe Gon\u00e7alves-de-Albuquerque C, Ribeiro Silva A, Ign\u00e1cio da Silva C, Caire Castro-Faria-Neto H, Burth P. Na\/K pump and beyond: Na\/K-ATPase as a modulator of apoptosis and autophagy. Molecules. 2017;22(4):578. https:\/\/doi.org\/10.3390\/molecules22040578.","journal-title":"Molecules"},{"issue":"1","key":"717_CR145","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neuroscience.2005.10.004","volume":"137","author":"WC Golden","year":"2006","unstructured":"Golden WC, Martin LJ. Low-dose Ouabain protects against excitotoxic apoptosis and up-regulates nuclear Bcl-2 in vivo. Neuroscience. 2006;137(1):133\u201344. https:\/\/doi.org\/10.1016\/j.neuroscience.2005.10.004. Epub 2005 Nov 16.","journal-title":"Neuroscience"},{"key":"717_CR146","doi-asserted-by":"publisher","first-page":"31972","DOI":"10.1038\/srep31972","volume":"6","author":"TH Holm","year":"2016","unstructured":"Holm TH, Isaksen TJ, Glerup S, Heuck A, B\u00f8ttger P, F\u00fcchtbauer EM, et al. Cognitive deficits caused by a disease-mutation in the \u03913 Na(+)\/K(+)-ATPase isoform. Sci Rep. 2016;6:31972. https:\/\/doi.org\/10.1038\/srep31972.","journal-title":"Sci Rep"},{"issue":"9","key":"717_CR147","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/ng.2358","volume":"44","author":"EL Heinzen","year":"2012","unstructured":"Heinzen EL, Swoboda KJ, Hitomi Y, Gurrieri F, Nicole S, de Vries B, et al. De Novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet. 2012;44(9):1030\u20134. https:\/\/doi.org\/10.1038\/ng.2358.","journal-title":"Nat Genet"},{"key":"717_CR148","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fphys.2016.00141","volume":"7","author":"BR Larsen","year":"2016","unstructured":"Larsen BR, Stoica A, MacAulay N. Managing brain extracellular K(+) during neuronal activity: the physiological role of the Na(+)\/K(+)-ATPase subunit isoforms. Front Physiol. 2016;7:141. https:\/\/doi.org\/10.3389\/fphys.2016.00141.","journal-title":"Front Physiol"},{"key":"717_CR149","doi-asserted-by":"publisher","first-page":"5293","DOI":"10.1038\/s41467-022-32990-x","volume":"13","author":"PT Nguyen","year":"2022","unstructured":"Nguyen PT, Deisl C, Fine M, Tippetts TS, Uchikawa E, Bai XC, et al. Structural basis for gating mechanism of the human sodium-potassium pump. Nat Commun. 2022;13:5293. https:\/\/doi.org\/10.1038\/s41467-022-32990-x.","journal-title":"Nat Commun"},{"key":"717_CR150","doi-asserted-by":"publisher","first-page":"102156","DOI":"10.1016\/j.ceca.2019.102156","volume":"86","author":"D Pavlovic","year":"2020","unstructured":"Pavlovic D. Endogenous cardiotonic steroids and cardiovascular disease, where to next? Cell Calcium. 2020;86:102156. https:\/\/doi.org\/10.1016\/j.ceca.2019.102156.","journal-title":"Cell Calcium"},{"key":"717_CR151","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ceca.2017.05.006","volume":"70","author":"F Mammano","year":"2018","unstructured":"Mammano F, Bortolozzi M. Ca2\u2009+\u2009signaling, apoptosis and autophagy in the developing cochlea: milestones to hearing acquisition. Cell Calcium. 2018;70:117\u201326. https:\/\/doi.org\/10.1016\/j.ceca.2017.05.006.","journal-title":"Cell Calcium"},{"issue":"8","key":"717_CR152","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.3390\/ijms19082314","volume":"19","author":"D Lichtstein","year":"2018","unstructured":"Lichtstein D, Ilani A, Rosen H, Horesh N, Singh SV, Buzaglo N, et al. Na\u207a, K\u207a-ATPase signaling and bipolar disorder. Int J Mol Sci. 2018;19(8):2314. https:\/\/doi.org\/10.3390\/ijms19082314.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"717_CR153","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pnpbp.2011.12.006","volume":"37","author":"U Banerjee","year":"2012","unstructured":"Banerjee U, Dasgupta A, Rout JK, Singh OP. Effects of lithium therapy on Na+-K+-ATPase activity and lipid peroxidation in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2012;37(1):56\u201361. https:\/\/doi.org\/10.1016\/j.pnpbp.2011.12.006.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"6","key":"717_CR154","doi-asserted-by":"publisher","first-page":"101355","DOI":"10.1016\/j.jbc.2021.101355","volume":"297","author":"S Ygberg","year":"2021","unstructured":"Ygberg S, Akkuratov EE, Howard RJ, Taylan F, Jans DC, Mahato DR, et al. A missense mutation converts the Na+,K+-ATPase into an ion channel and causes therapy-resistant epilepsy. J Biol Chem. 2021;297(6):101355. https:\/\/doi.org\/10.1016\/j.jbc.2021.101355.","journal-title":"J Biol Chem"},{"key":"717_CR155","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.freeradbiomed.2013.02.018","volume":"60","author":"MA Abdelmegeed","year":"2013","unstructured":"Abdelmegeed MA, Jang S, Banerjee A, Hardwick JP, Song BJ. Robust protein nitration contributes to acetaminophen-induced mitochondrial dysfunction and acute liver injury. Free Radic Biol Med. 2013;60:211\u201322. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.02.018.","journal-title":"Free Radic Biol Med"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00717-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-025-00717-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00717-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T13:11:25Z","timestamp":1747055485000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-025-00717-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":155,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["717"],"URL":"https:\/\/doi.org\/10.1007\/s43440-025-00717-6","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"assertion":[{"value":"27 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}